ISSN:
1432-1041
Keywords:
European Drug Agency
;
drug-lag
;
European integrated market post 1992
;
pharmaceuticals
;
marketing authorization
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
,
Medicine
Notes:
Summary The European Community (EC) is scheduled to become a fully integrated market by 1992. Currently the present national variations in pharmaceutical marketing authorization constitutes an unresolved barrier. The need is for agreed and clearly specified requirements to afford EC wide marketing authorization within agreed time frames. Great care will be required to avoid such problems as a European drug-lag and mounting cost, to the detriment of patients, government, and the research-based pharmaceutical industry
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00558119
Permalink
